Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cellular Therapy and Transplantation is Scopus-indexed (Q4, CiteScore 0.4). Published by Universitatsklinikum Hamburg - Eppendorf.
Checked against the index lists dated .
ISSN 1866-8836Verify ISSN ↗1867-416XVerify ISSN ↗
Publisher: Universitatsklinikum Hamburg - Eppendorf
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Transplantation | 51 / 55 | 8th | Q4 |
| Molecular Medicine | 175 / 179 | 2nd | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2015–present (also 2009–2011), best quartile Q4, CiteScore 0.4.
Cellular Therapy and Transplantation is Q4 in Transplantation (rank 51 of 55) and Q4 in Molecular Medicine (rank 175 of 179), by CiteScore 2025.
Cellular Therapy and Transplantation is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.4, quartile Q4, 8th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.130, quartile Q4, with an H-index of 9.
Cellular Therapy and Transplantation is published by Universitatsklinikum Hamburg - Eppendorf. Its print ISSN is 1866-8836 and its online ISSN is 1867-416X.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Cellular Therapy and Transplantation has an h-index of 9 and a 2-year mean of 0.26 citations per paper (OpenAlex). Its Scopus CiteScore is 0.4, quartile Q4. On 2-year citations it ranks #51 of 53 Scopus journals in Transplantation.
Cellular Therapy and Transplantation published 38 papers in 2025; its busiest recent year was 2017 with 57. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 43 research articles (2023–2026), authors are most often from Russia (82.6%), United States (3.5%) and Malaysia (2.3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.